VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 178 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $288,927 | -32.0% | 39,097 | -9.1% | 0.00% | -25.0% |
| Q3 2022 | $425,000 | -24.5% | 43,028 | -16.6% | 0.00% | 0.0% |
| Q2 2022 | $563,000 | +2.0% | 51,595 | +5.7% | 0.00% | +33.3% |
| Q1 2022 | $552,000 | -16.6% | 48,802 | +15.6% | 0.00% | 0.0% |
| Q4 2021 | $662,000 | -28.4% | 42,220 | -21.8% | 0.00% | -50.0% |
| Q3 2021 | $925,000 | +93.1% | 53,979 | +142.2% | 0.01% | +100.0% |
| Q2 2021 | $479,000 | -68.4% | 22,287 | -84.8% | 0.00% | -25.0% |
| Q3 2014 | $1,518,000 | -27.4% | 146,195 | +13.2% | 0.00% | -20.0% |
| Q2 2014 | $2,090,000 | -12.0% | 129,156 | -11.6% | 0.01% | -28.6% |
| Q1 2014 | $2,375,000 | +21.0% | 146,148 | -7.6% | 0.01% | +16.7% |
| Q4 2013 | $1,963,000 | – | 158,174 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |